113 related articles for article (PubMed ID: 1805937)
1. Technetium labeling of monoclonal antibodies with functionalized BATOs: 2. TcCl(DMG)3CPITC labeling of B72.3 and NP-4 whole antibodies and NP-4 F(ab')2.
Linder KE; Wen MD; Nowotnik DP; Ramalingam K; Sharkey RM; Yost F; Narra RK; Nunn AD; Eckelman WC
Bioconjug Chem; 1991; 2(6):407-14. PubMed ID: 1805937
[TBL] [Abstract][Full Text] [Related]
2. Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC.
Linder KE; Wen MD; Nowotnik DP; Malley MF; Gougoutas JZ; Nunn AD; Eckelman WC
Bioconjug Chem; 1991; 2(3):160-70. PubMed ID: 1932215
[TBL] [Abstract][Full Text] [Related]
3. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
[TBL] [Abstract][Full Text] [Related]
4. Boronic acid adducts of technetium dioxime (BATO) complexes derived from quinuclidine benzilate (QNB) boronic acid stereoisomers: syntheses and studies of their binding to the muscarinic acetylcholine receptor.
Jurisson SS; Pirro J; DiRocco RJ; Rosenspire KC; Jagoda E; Nanjappan P; Eckelman WC; Nowotnik DP; Nunn AD
Nucl Med Biol; 1995 Apr; 22(3):269-81. PubMed ID: 7627141
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of 99mTc-metallothionein-B72.3 and its F(ab')2 fragment.
Brown BA; Dearborn CB; Drozynski CA; Sands H
Cancer Res; 1990 Feb; 50(3 Suppl):835s-839s. PubMed ID: 2297730
[TBL] [Abstract][Full Text] [Related]
6. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
[TBL] [Abstract][Full Text] [Related]
8. A new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibody.
Ranadive GN; Rosenzweig HS; Epperly MW; Seskey T; Bloomer WD
Nucl Med Biol; 1993 Aug; 20(6):719-26. PubMed ID: 8401372
[TBL] [Abstract][Full Text] [Related]
9. Site-specific modifications of light chain glycosylated antilymphoma (LL2) and anti-carcinoembryonic antigen (hImmu-14-N) antibody divalent f1agments.
Govindan SV; Goldenberg DM; Griffiths GL; Leung SO; Losman MJ; Hansen HJ
Cancer Res; 1995 Dec; 55(23 Suppl):5721s-5725s. PubMed ID: 7493334
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and in vitro evaluation of nitroimidazole--BATO complexes: new technetium compounds designed for imaging hypoxic tissue.
Linder KE; Chan YW; Cyr JE; Nowotnik DP; Eckelman WC; Nunn AD
Bioconjug Chem; 1993; 4(5):326-33. PubMed ID: 8274515
[TBL] [Abstract][Full Text] [Related]
11. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibody CEA 102: whole IgG versus F(ab')2 fragments].
Wada K; Watanabe T; Tadokoro M; Sakamoto J; Murayama H; Sakuma S; Takagi H
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):266-73. PubMed ID: 1513308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a direct method for technetium labeling intact and F(ab')2 1A3, an anticolorectal monoclonal antibody.
Schwarz SW; Connett JM; Anderson CJ; Rocque PA; Philpott GW; Guo LW; Welch MJ
Nucl Med Biol; 1994 May; 21(4):619-26. PubMed ID: 9234319
[TBL] [Abstract][Full Text] [Related]
13. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
14. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
Int J Cancer; 1989 Aug; 44(2):292-300. PubMed ID: 2759735
[TBL] [Abstract][Full Text] [Related]
15. Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice.
Sharkey RM; Boerman OC; Natale A; Pawlyk D; Monestier M; Losman MJ; Goldenberg DM
Int J Cancer; 1992 May; 51(2):266-73. PubMed ID: 1568794
[TBL] [Abstract][Full Text] [Related]
16. Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.
Storto G; Buchegger F; Waibel R; Kuenzi G; Offord RE; Schubiger PA; Gillet M; Delaloye AB
Cancer Biother Radiopharm; 2001 Oct; 16(5):371-9. PubMed ID: 11776754
[TBL] [Abstract][Full Text] [Related]
17. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
Behr T; Becker W; Hannappel E; Goldenberg DM; Wolf F
Cancer Res; 1995 Dec; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
[TBL] [Abstract][Full Text] [Related]
18. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
[TBL] [Abstract][Full Text] [Related]
19. Preparation of a pure 99mTc-F(ab')2 radioimmunoconjugate by direct labeling methods.
Griffiths GL; Goldenberg DM; Jones AL; Hansen HJ
Nucl Med Biol; 1994 May; 21(4):649-55. PubMed ID: 9234323
[TBL] [Abstract][Full Text] [Related]
20. Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA).
Robert B; Dorvillius M; Buchegger F; Garambois V; Mani JC; Pugnières M; Mach JP; Pèlegrin A
Int J Cancer; 1999 Apr; 81(2):285-91. PubMed ID: 10188732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
